Clinical trial
Hepcidin Levels in Sickle Cell Disease (SCD)
NCT02258997 is registered in ClinicalTrials.gov with Kenneth Ataga, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hepcidin Levels in Sickle Cell Disease (SCD)
- Lead sponsor
- Kenneth Ataga, MD
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2014
- Completion date
- September 30, 2015
- Enrollment
- 42 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
sickle - beta thalassemia, sickle cell anemia